All productsTB-500
Size
- 10 mg — $50.00 CAD — Available
Research focus
TB-500 identification research distinguishes an acetylated peptide fragment from full-length thymosin beta-4.
In simple words
TB-500 is a name used for a peptide fragment associated with thymosin beta-4. The selected identification study examined N-acetylated LKKTETQ, not the full-length protein; the catalogue name alone does not confirm the vial’s sequence.
The reviewed TB-500 study identified N-acetylated LKKTETQ. The catalogue name alone does not confirm that sequence; full-length thymosin beta-4 is different.
Research references
Reviewed 2026-10-26
Analytical — laboratory and horses
Equine urine/plasma and in-vitro metabolism; horse count not stated in the reviewed abstract.
The preparation tested contained N-acetylated LKKTETQ, a fragment of thymosin beta-4. Researchers developed a method to detect it and its metabolites.
This was a detection study, not a healing trial. Full-length thymosin beta-4 research cannot automatically be attributed to TB-500-labelled products.
PMID 23084823. Indexed abstract checked through Europe PMC on 2026-10-26. Selected evidence, not a systematic review.
Resources
Compound name and formula checked via PubChem PUG REST. This reference does not verify the vial, salt or formulation.
PubChemMechanism and target search. Automated access returned 403; DrugBank was not used to substantiate claims or approval status.
DrugBankProtein/precursor search, not a record of the supplied vial. Synthetic compounds and lab supplies may have no matching protein entry.
UniProtBioactivity search. Assay results depend on the tested compound, target and experimental conditions.
ChEMBLExplore indexed literature. Search results are not supporting citations; selected verified publications appear above.
PubMedExplore registrations. A match or completed study does not establish efficacy, approval or relevance to this vial.
ClinicalTrials.govEvidence on studied compounds does not establish the identity, purity, safety, or regulatory approval of the catalogue vial. No Canadian regulatory status is assessed here.
Research questions about TB-500
What is TB-500?
TB-500 is a name used for a peptide fragment associated with thymosin beta-4. The selected identification study examined N-acetylated LKKTETQ, not the full-length protein; the catalogue name alone does not confirm the vial’s sequence.
What types of research are cited for TB-500?
The TB-500 profile contains the following selected evidence. This is not a systematic review or a complete inventory of research.
TB-500 identity and equine detection (2012): Analytical — laboratory and horses
Publication: TB-500 identity and equine detectionWho or what was studied in the selected TB-500 references?
TB-500 identity and equine detection (2012): Equine urine/plasma and in-vitro metabolism; horse count not stated in the reviewed abstract.
Publication: TB-500 identity and equine detectionWhat identity distinctions matter for TB-500?
The reviewed TB-500 study identified N-acetylated LKKTETQ. The catalogue name alone does not confirm that sequence; full-length thymosin beta-4 is different.
What do the selected TB-500 studies not establish?
TB-500 identity and equine detection (2012): This was a detection study, not a healing trial. Full-length thymosin beta-4 research cannot automatically be attributed to TB-500-labelled products.
Publication: TB-500 identity and equine detectionThese studies do not establish the identity, purity, safety or effects of the MXC TB-500 vial. Findings in one formulation, population or experimental model should not be assumed to apply to another.